Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ActHIB® safely and effectively. See full prescribing information for ActHIB. ActHIB [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] Solution for Intramuscular InjectionInitial U.S. Approval: 1993
Medication labelWhy this: Advisory · dailymed-other
ActHIB® is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae (H. influenzae) type b. ActHIB is approved for use in children 2 months through 5 years of age.
- generic_name
- haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
- brand_name
- Sodium Chloride
- product_names
- HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, Sodium Chloride
- ndc
- 49281-545, 49281-545-03, 49281-547, 49281-547-58, 49281-546, 49281-546-58
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en